⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockSwitzerlandNasdaqGS

NVCR

NovoCure Limited

Healthcare · Medical Devices

15.63USD

-1.2200 (-7.24%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 15.63
P/E—
Dvd Ind Yld—
P/B5.80
P/S2.8
Curr EV/T12M EBITDA-12.9
Mkt Cap (USD)2.0B
Curr EV (USD)1.8B
2)

Per Share Data

EPS T12M-1.30
DPS0.00
Bk Val Per Sh2.90
Rev/Sh6.03
Cash/Sh3.78
Curr Shares Out116.4M
FCF/Sh-0.22
3)

Cash Flow Analysis

P/CF-697.0
Curr P/FCF-77.1
CF/NI0.0
Dvd P/O0.0%
Cash Gen/Cash Reqd-0.1
Csh Dvd Cov—
CFO/Sales-0.4%
Eff Interest Rate5.8%
4)

Growth Potential

Dil EPS 1Y Gr21.8%
Cap 1Y Gr17.1%
BPS 1Y Gr-8.6%
R&D To Sales32.1%
Retention Rate100.0%
Rev 1Y Gr8.3%
FCF 1Y Gr-9.3%
Assets 1Y Gr-35.2%
5)

Profitability

EBITDA-0.1B
EBIT-0.2B
Operating Margin-22.1%
Pretax Margin-21.8%
Net Margin-21.2%
ROA-14.6%
ROE-43.2%
ROC-26.3%
Asset Turnover0.69
6)

Structure

Current Ratio2.89
Quick Ratio2.66
Debt/Assets29.4%
Debt/Com Eq69.0%
Net Debt/EBITDA-1.01
Tot Debt/Capital40.8%
Gross Margin76.1%
EBIT/Int Exp-6.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.